Elenco delle pubblicazioni del Think Tank del PE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Elenco delle pubblicazioni del Think Tank del PE
https://www.europarl.europa.eu/thinktank
Criteri di ricerca utilizzati per generare l''elenco :
Ordina Mostra per data
Parole chiave "diritti del malato"
21 Risultati(i)
Data di creazione : 05-10-2022Artificial intelligence in healthcare: Applications, risks, and ethical and societal impacts
Tipo di pubblicazioneStudio
Data
01-06-2022
Autore esterno DG, EPRS
Settore di intervento
Politica di ricerca
Parole chiaveattrezzature medico-chirurgiche | diagnostica medica | diritti del malato | intelligenza artificiale | sicurezza dei pazienti |
tecnologia | trattamento sanitario
Riassunto In recent years, the use of artificial intelligence (AI) in medicine and healthcare has been praised for the great promise
it offers, but has also been at the centre of heated controversy. This study offers an overview of how AI can benefit
future healthcare, in particular increasing the efficiency of clinicians, improving medical diagnosis and treatment, and
optimising the allocation of human and technical resources. The report identifies and clarifies the main clinical, social
and ethical risks posed by AI in healthcare, more specifically: potential errors and patient harm; risk of bias and
increased health inequalities; lack of transparency and trust; and vulnerability to hacking and data privacy breaches.
The study proposes mitigation measures and policy options to minimise these risks and maximise the benefits of
medical AI, including multi-stakeholder engagement through the AI production lifetime, increased transparency and
traceability, in-depth clinical validation of AI tools, and AI training and education for both clinicians and citizens.
Studio EN
Boosting cooperation on health technology assessment
Tipo di pubblicazione Briefing
Data 09-12-2021
Autore AMAND-EECKHOUT Laurence
Settore di intervento Sanità pubblica
Parole chiave attrezzature medico-chirurgiche | cooperazione scientifica | cooperazione transfrontaliera | diritti del malato |
innovazione | proposta (UE) | sanità pubblica | scambio d'informazioni | scienze mediche | trattamento sanitario |
valutazione tecnologica
Riassunto The European Commission has proposed a regulation on health technology assessment (HTA). HTA is a research-
based tool that supports decision-making in healthcare by assessing the added value of a given health technology
compared to others. The proposal would provide the basis for permanent EU-level cooperation in four areas. Member
States would still be responsible for assessing the non-clinical (economic, ethical, social, etc.) aspects of health
technology, and for pricing and reimbursement. While Member States could choose to delay participation in the joint
work until three years after the rules enter into force, it would become mandatory after six years. The European
Parliament adopted its final position at first reading on 14 February 2019. In the Council, work was carried out under
seven consecutive presidencies. On 22 June 2021, the co-legislators reached a provisional agreement in
interinstitutional trilogue negotiations. The Council's Permanent Representatives Committee endorsed the provisional
agreement on 30 June 2021. Parliament's ENVI committee voted in favour of the text on 13 July 2021. The Council
formally adopted its first-reading position on 9 November 2021. On 30 November 2021, ENVI adopted its
recommendation for second reading, which is to be debated and voted during the December plenary session. The
regulation, once adopted, will start to apply three years after its entry into force. Fifth edition of a briefing originally
drafted by Nicole Scholz. The 'EU Legislation in Progress' briefings are updated at key stages throughout the
legislative procedure.
Briefing EN
Research for REGI Committee - Cross-border cooperation in healthcare
Tipo di pubblicazione In sintesi
Data 10-11-2021
Autore DIETZEN Stephan Klaus | LECARTE Jacques
Settore di intervento Sviluppo regionale | Valutazione del diritto e delle politiche nella pratica
Parole chiave cooperazione transfrontaliera | direttiva (UE) | diritti del malato | diritti sociali | prestazione di servizi | sanità pubblica |
sicurezza sociale | trattamento sanitario
Riassunto This At a glance note summarises the study that analyses the role of Cohesion Policy as regards cross-border
cooperation in healthcare, with a particular focus on the 2014-2020 Interreg V-A programmes. The study also reviews
the issue of governance related to such projects and the impact of the COVID-19 pandemic. Finally, it identifies
possible solutions and puts forward policy recommendations to facilitate patient and healthcare staff flows, to improve
the cross-border supply of healthcare and to support cross-border mutual development.
In sintesi EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 1Access to medicinal products
Tipo di pubblicazione Studio
Data 01-05-2021
Autore esterno Thyra de Jongh, Lennart Velten, Lonneke Schrijver
Settore di intervento Democrazia UE | Democrazia UE, diritto istituzionale e parlamentare | Diritto UE: sistema e atti giuridici | Pianificazione
preventiva | Sanità pubblica
Parole chiave cooperazione transfrontaliera | diritti del malato | diritto alla salute | eHealth | epidemia | malattia da coronavirus |
medicinale | penuria | rapporto di ricerca | recesso dall'UE | Regno Unito | risoluzione PE
Riassunto There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from
selective marketing decisions by companies to products being too expensive or pharmacy stock-outs. Because of
national differences in health systems and market characteristics, access to medicine is not evenly distributed across
the European Union. In response to observed problems with access to medicine, in 2017 the European Parliament
adopted a resolution containing 58 recommendations for action to the European Commission and Member States. This
In-Depth Analysis reviews the main actions taken at the Union level since then that could improve access to medicine.
It also includes illustrative examples of actions taken by Member States and other actors. The analysis concludes that
the Commission has proposed or taken a combination of legislative and non-legislative actions with the potential to
improve access to medicine in the Union and beyond, but that it will take time for the effects of these to become clear.
Studio EN
Strengthening EU cooperation on health technology assessment
Tipo di pubblicazione Briefing
Data 18-06-2018
Autore VETTORAZZI STEFANO
Settore di intervento Sanità pubblica
Parole chiave accesso al mercato | attrezzature medico-chirurgiche | cooperazione scientifica | cooperazione transfrontaliera | diritti
del malato | innovazione | proposta (UE) | sanità pubblica | scambio d'informazioni | scienze mediche | studio d'impatto
| trattamento sanitario | valutazione tecnologica
Riassunto The impact assessment (IA) accompanying the Commission proposal on strengthening EU cooperation on Health
Technology Assessment clearly defines the problem, as well as the general and specific objectives. However, the IA
does not appear to have succeeded in presenting a very convincing range of options. The analysis of impacts focuses
on the economic dimension, which is consistent with the manner in which the problems have been defined. In light of
the reported concentration of SMEs in the medical technologies sector (95 %), more emphasis could have been put on
analysing the impacts of the retained options on them. The stakeholders' views have been illustrated in a satisfactory
way. The evidence included or referenced in the IA is copious and up to date. The IA appears to have addressed most
of the RSB's recommendations. Finally, the legislative proposal appears to be consistent with the analysis carried out
in the IA.
Briefing EN
Understanding European Reference Networks: Cooperation on rare diseases across Europe
Tipo di pubblicazione Briefing
Data 09-06-2017
Autore SCHOLZ Nicole
Settore di intervento Sanità pubblica
Parole chiave cooperazione transfrontaliera | diritti del malato | diritto dell'UE | malattia rara | programma quadro di ricerca e sviluppo
| rete di trasmissione | ricerca medica | scambio d'informazioni | sistema sanitario | telemedicina
Riassunto European Reference Networks (ERNs) are newly established virtual platforms for voluntary cross-border collaboration
between specialists in rare and complex diseases. ERNs were set up under Directive 2011/24/EU on the application of
patients' rights in cross-border healthcare, and go back to a 2009 Council recommendation on an action in the field of
rare diseases. Since specialist knowledge of rare diseases is both scarce and scattered across countries, the EU-level
cooperation afforded by ERNs is regarded as bringing added value through maximising synergies. Currently, 24
thematic ERNs involve more than 900 specialised healthcare teams in over 300 hospitals in 25 EU Member States
plus Norway. A public consultation fed into the establishment of the ERNs, and a number of stakeholder views were
presented on the occasion of their launch. The ERN initiative has generally been well received. According to
stakeholders, its strengths include opportunities for carrying out research and new treatments, breaking the isolation of
specialists and patients, reducing inequalities in care, and fostering patient involvement. Among the challenges that
need to be addressed, stakeholders mention questions concerning reimbursement, interoperability and data
confidentiality, and legal issues. The ERNs are currently in their deployment phase, and expected to reach full capacity
over the next five years.
Briefing EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 2Medical devices and in vitro diagnostic medical devices
Tipo di pubblicazione Briefing
Data10-05-2017
AutoreSCHOLZ Nicole
Settore di interventoAdozione della legislazione da parte del PE e del Consiglio | Sanità pubblica
Parole chiave attrezzature medico-chirurgiche | diritti del malato | elaborazione del diritto dell'UE | omologazione | responsabilità del
produttore | sicurezza del prodotto
Riassunto Medical devices and in vitro diagnostic medical devices cover a wide array of products. The EU legal framework for
such devices was harmonised in the 1990s. The European Commission presented a pair of proposals for regulations
in September 2012. Following Parliament's first readings in April 2014, the Council agreed its positions in October
2015. At the conclusion of the trilogues, agreement was reached on 25 May 2016. This was endorsed by the Council's
Permanent Representatives Committee on 15 June and confirmed by Parliament's ENVI Committee on the same day.
Both draft texts were adopted by the Council on 7 March 2017, and Parliament's second-reading vote on 5 April
completed the adoption procedure. The regulation on medical devices will become fully applicable in May 2020, and
that on in vitro diagnostic medical devices in May 2022.
Briefing EN
Public expectations and EU policies - Health and social security
Tipo di pubblicazione Briefing
Data 30-06-2016
Autore DOBREVA Alina | EATOCK David | MILOTAY Nora | PARRY Matthew | SCHOLZ Nicole
Settore di intervento Politica sociale | Sanità pubblica
Parole chiave bilancio dell'UE | competenza dell'UE | diritti del malato | equilibrio tra vita professionale e vita privata | esperimento
sull'uomo | finanziamento dell'UE | integrazione sociale | legislazione sanitaria | parità di trattamento | politica sociale
europea | programma dell'UE | sicurezza sociale | situazione dell'Unione europea | sondaggio di opinione |
sorveglianza dei medicinali
Riassunto Almost two thirds of EU citizens would like to see more EU engagement in the areas of health and social security. The
EU's main role in these policies is to support and complement the activities of Member States, and it can encourage
cooperation and best practice. EU health policy aims to foster good health, protect citizens from health threats and
support dynamic health systems. Social policy promotes social cohesion equality as well as solidarity through
adequate, accessible and financially sustainable social protection systems and social inclusion policies. The EU
encourages national pension reforms to ensure they are both adequate and sustainable. In the EU budget, the Health
Programme 2014-2020 is the only programme specifically created for this policy area, but other programmes
contribute in part to health objectives. EU spending on social security is tied to labour market measures.
Briefing EN
Medical devices and in vitro diagnostic medical devices
Tipo di pubblicazione Briefing
Data07-06-2016
AutoreSCHOLZ Nicole
Settore di interventoAdozione della legislazione da parte del PE e del Consiglio | Sanità pubblica
Parole chiave attrezzature medico-chirurgiche | diritti del malato | elaborazione del diritto dell'UE | omologazione | responsabilità del
produttore | sicurezza del prodotto
Riassunto Medical devices and in vitro diagnostic medical devices cover a wide array of products, from sticking plasters, to heart
valves, to state-of-the-art analytical laboratory equipment, with over 500 000 devices on the EU market. The EU legal
framework for such devices was harmonised in the 1990s. The European Commission presented a pair of proposals
for regulations in September 2012, to update the framework. Following Parliament's first readings in April 2014, the
Council agreed its positions in October 2015. At the conclusion of the tenth trilogue meeting, agreement was reached
on both proposals on 25 May 2016. The compromise centres on stricter requirements for notified bodies, stronger pre-
market scrutiny and post-marketing surveillance; strengthened rules for high-risk devices and certain other categories
of devices; and increased transparency and traceability. This updates a previous edition from December 2015: PE
572.819.
A more recent edition of this document is available. Find it by searching by the document title at this address:
http://www.europarl.europa.eu/thinktank/en/home.html
Briefing EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 3What if others could read your mind?
Tipo di pubblicazione In sintesi
Data 08-04-2016
Autore BOUCHER Philip Nicholas | KRITIKOS Michail | VAN WOENSEL Lieve
Settore di intervento Politica di ricerca
Parole chiave attrezzature medico-chirurgiche | bioetica | diritti del malato | diritto sanitario | handicappato fisico | impatto delle
tecnologie dell'informazione | prospettiva tecnologica | protezione dei dati | protezione della vita privata | ricerca
medica
Riassunto Brain-computer interface technology has been advancing rapidly and will continue to do so as our knowledge of how
the brain works increases. Could this transform our understanding of life as we know it? A brain-computer interface
(BCI) is a direct communication pathway between the brain and an external device. This technology can be used to
restore motor and sensory capacities which may have been lost through trauma, disease or congenital conditions. For
example, combined with limb-replacement technology, BCI may allow patients not only to move prosthetic limbs, but
also to feel the sensation of touch. The technology can either be implanted (invasive) or used externally (non-invasive).
Invasive BCIs, including neuroprosthetics and brain implants, are devices which connect directly to the brain and are
placed on its surface or attached to the cortex. A key application area for contemporary brain implant research is the
development of biomedical prostheses to circumvent areas of the brain that have become dysfunctional after a stroke
or other trauma. With deep brain stimulation, a 'brain pacemaker' sends electrical impulses to specific parts of the brain
for the treatment of disorders such as Parkinson's disease, dystonia and major depression. Non-invasive BCIs consist
of a range of technological devices which provide a similar interface between the brain and other machines without the
need for surgery. There are several technologies capable of measuring and recording brain activity, although the signal
quality may be weaker than is possible with implanted devices. Nonetheless, non-invasive BCIs have been used
effectively, for example to control prosthetic hands.
In sintesi EN
Multimedia What if others could read your mind?
Need for action on dementia recalled
Tipo di pubblicazione Briefing
Data12-02-2016
AutoreSCHOLZ Nicole
Settore di interventoSanità pubblica
Parole chiave diritti del malato | malattia del sistema nervoso | malattia mentale | prevenzione delle malattie | progetto di ricerca |
programma dell'UE | ricerca medica | trattamento sanitario
Riassunto Dementia is one of Europe's biggest challenges in the context of demographic change. It has wide-ranging social and
economic consequences for those living with the condition, their families and carers, and society as a whole. The
Council's conclusions of December 2015 acknowledge the importance of this challenge. Dementia is not one specific
disease, but an overall term for a syndrome that affects memory, thinking, orientation, comprehension, calculation,
learning capacity, language and judgement. There are many different causes and forms of dementia. The condition
remains little understood, and there is currently no cure. Action to tackle dementia is centred on its prevention, early
detection and timely diagnosis, and on improving the quality of life of those living with it through care and support.
Research focuses on the causes and possible treatments, on better care and prevention, as well as on developing
assistive technologies. The European Commission has published a communication on dementia, undertaken various
activities and funded research. A European Parliament resolution from 2011 called for dementia to be made a health
priority. Major global dementia initiatives include a G8 declaration, the creation of the World Dementia Council, and the
first Ministerial Conference on 'Global Action Against Dementia', hosted by the World Health Organization. Civil society
is also actively involved.
Briefing EN
Data Saves Lives: The Impact of the Data Protection Regulation on Personal Data Use in Cancer
Research
Tipo di pubblicazioneStudio
Data
15-01-2016
Autore esterno Paola BANFI, Rachel DEMPSEY, Manon EMONTS and Hana SPANIKOVA
Settore di intervento
Pianificazione preventiva | Sanità pubblica
Parole chiavebioetica | cancro | dati medici | dati personali | diritti del malato | elaborazione del diritto dell'UE | memorizzazione dei
dati | protezione dei dati | raccolta dei dati | ricerca medica
Riassunto This report summarises the presentations and discussions of the workshop on data saves lives, held at the European
Parliament in Brussels on Thursday 19 November 2015. The aim of the workshop was to provide background
information and advice regarding the proposed General Data Protection Regulation and the impact it may have on the
use of personal health data in cancer research.
During the first part of the workshop the policy context and state of play of the proposed new Regulation were
presented. An update on the Trilogue discussions and latest amendments to the text of the Regulation were given;
obstacles and opportunities for harmonisation of cancer data were also discussed.
The second part of the workshop focused on the impact of the proposed Regulation on cancer research. Access to
data, ethical standards, data storage, and a European project on cancer survival were covered during this session. All
presentations highlighted the need for a broad consent (a one-time consent given by data subjects to allow the use of
their data for a variety of research studies which are subject to strict criteria) in order to make cancer research
possible.
Finally, future developments based on the experience of healthcare providers, patients and the industries were
discussed. Possible practical solutions were given that could solve the obstacles of the proposed Regulation faced by
the cancer research community.
Studio EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 4Safer Healthcare in Europe: Improving Patient Safety and Fighting Antimicrobial Resistance
Tipo di pubblicazione Studio
Data 13-07-2015
Autore esterno Piernicola PEDICIN (MEP, European Parliament), Maria IGLESIA (European Commission), Dominique MONNET
(European Centre for Disease Prevention and Control - ECDC), Cristina PADEANU (European Patients’ Forum - EPF),
Andrea SORICELLI (University Parthenope of Naples ; Institute of Diagnostic and Nuclear Development - SDN
Foundation), Marta HUGAS (European Food Safety Agency - EFSA), Antoine ANDREMONT (Hôpital Bichat Claude-
Bernard, AP-HP) and Janice SCOTT (Royal Free London NHS Foundation Trust)
Settore di intervento Sanità pubblica
Parole chiave antibiotico | attrezzature medico-chirurgiche | diagnostica medica | diritti del malato | diritto alla salute | farmaco
generico | malattia infettiva | prevenzione delle malattie | ricerca medica | rischio sanitario | trattamento sanitario
Riassunto This report summarises the presentations and discussions at the Workshop on ‘Safer healthcare in Europe: improving
patient safety and fighting antimicrobial resistance’, held at the European Parliament in Brussels, on Tuesday 24
February 2015. The aim of the workshop was to discuss the main challenges and future perspectives related to the
topic of patient safety and the threat of antimicrobial resistance in Europe. The workshop was hosted by MEP
Piernicola PEDICINI, ENVI Committee Rapporteur for the Parliament’s own initiative report on this topic.
Studio EN
Workshop Proceedings on "e-Health"
Tipo di pubblicazione Studio
Data 15-11-2013
Autore esterno Benoît Abeloos (DG CONNECT, European Commission), Jerome Boehm (DG SANCO, European Commission), Juan
Fernando Muñoz Montalvo (Information Technology, Spanish Ministry, Spain), Jillian Oderkirk (Health Information
Infrastructure Project, Health Division, OECD), Diana Zandi (eHealth Unit, WHO), Raul Mill (Estonian eHealth
Foundation, Estonia), Siri Bjørvig (Norwegian Centre for Integrated Care and Telemedicine, Norway), Vicent Moncho
Mas (Hospital Marina Salud, Denia, Spain), Antoine Geissbühler (Geneva University School of Medicine , Geneva
University Hospitals, Switzerland), Nathalie Chaze (DG SANCO, European Commission), Georges De Moor (Gent
University, Belgium), Lisa Hagberg (Swedish Association of Local Authorities and Regions, Sweden), Hartmut Schaper
(Siemens Healthcare), Ray Pinto (Microsoft Europe), Nicola Bedlington (European Patient Forum), Sascha Marschang
(European Public Health Alliance) and Konstanty Radziwiłł (eHealth Working Group of the Standing Committee of
European Doctors)
Settore di intervento Sanità pubblica
Parole chiave applicazione dell'informatica | costo della salute | diritti del malato | Estonia | progetto di ricerca | ricerca medica |
sistema sanitario | Spagna | spese sanitarie | telemedicina
Riassunto This report summarises the presentations and discussions at the Workshop on e-Health, held at the European
Parliament in Brussels, on Tuesday 24 September 2013. The workshop was held in view of the finalisation of the ENVI
Committee’s Own Initiative Report on the e-Health Action Plan 2012-2020 – Innovative healthcare for the 21st century’,
which will serve as a basis for the adoption of a European Parliament resolution. The workshop was hosted by MEP
Ms Pilar AYUSO (EPP, ES), Rapporteur of the ENVI Committee’s Own Initiative Report, and MEP Ms Jill EVANS (The
Greens/EFA, UK), MEP Mr James NICHOLSON (ECR, UK), MEP Ms Antonyia PARVANOVA (ALDE, BG), and MEP
Mr Claudiu C. TĂNĂSESCU (S&D, RO) who contributed to the Own Initiative Report as Shadow Rapporteurs.
Studio EN
Psychiatry as a Tool for Coercion in Post-Soviet Countries
Tipo di pubblicazione Analisi approfondita
Data 16-07-2013
Autore esterno Robert VAN VOREN (Federation Global Initiative on Psychiatry - FGIP , Soviet and Post-Soviet Studies at Ilia State
University in Tbilisi, Georgia , Vytautas Magnus University in Kaunas, Lithuania)
Settore di intervento Affari esteri | Diritti dell''uomo | Sanità pubblica
Parole chiave corruzione | diritti del malato | dissidenza | internamento in ospedale psichiatrico | malattia mentale | Russia | Ucraina
Riassunto During the 1960-1980s in the USSR, psychiatry was turned into a tool of repression. Soviet psychiatry was cut off from
world psychiatry and developed its own - highly institutional and biologically oriented – course, providing at the same
time a “scientific justification” for declaring dissidents mentally ill. Since the collapse of the USSR there have been
frequent reports of persons hospitalized for non-medical reasons, mostly in the Russian Federation and Ukraine.
The abuses are caused by an underdeveloped mental health profession with little knowledge of medical ethics and
professional responsibilities of physicians; by a system that is highly abusive and not able to guarantee the rights of
patients; because of corrupt societies where also psychiatric diagnoses are for sale; because of lack of financing and
interest by the authorities and in some cases because of a deteriorating political climate in which local authorities feel
safe to use psychiatry again as a tool of repression.
Through targeted interventions from outside the situation could be considerably ameliorated and a clear break with the
past could be made possible. In this respect the European Parliament can play a crucial role in empowering those who
wish to make a clear break with the Soviet past.
Analisi approfondita EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 5Proceedings of the Workshop on "Patient Safety"
Tipo di pubblicazione Studio
Data 14-06-2013
Autore esterno Nathalie Chaze (DG Health and Consumers, European Commission), Fabrizio Oleari (Istituto Superiore di Sanità,
Italy), Boudewijn Catry (Healthcare-Associated Infections and Antimicrobial Resistance, Public Health & Surveillance,
Scientific Institute of Public Health, Belgium), Olivier Patey (Internal Medicine Service, Infectious and Tropical
Diseases, CHI Villeneuve Saint Georges, France), Agnès Leotsakos (Patient Safety Education and Global Capacity
Building, World Health Organization), Dominique L. Monnet (European Centre for Disease Prevention and Control),
Zena Moore (European Wound Management Association), Cristina Padeanu (European Patients’ Forum) and Nöel
Wathion (Patient Health Protection, European Medicines Agency)
Settore di intervento Sanità pubblica
Parole chiave diritti del malato | epidemiologia | igiene pubblica | malattia infettiva | ospedalizzazione | prevenzione delle malattie |
ricerca medica | servizio sanitario | terapeutica | trattamento sanitario
Riassunto This report summarises the presentations and discussions at the Workshop on "Patient Safety", held at the European
Parliament in Brussels, on Thursday 30 May 2013. The aim of the workshop was to discuss some of the challenges
related to this topic and to provide input into the Parliament’s own-initiative report on the implementation of the Council
Recommendation on patient safety.
The workshop was hosted by MEP Mr Oreste ROSSI (EPP, IT), ENVI Committee Rapporteur for the INI report, and
co-chaired by MEP Ms Michèle RIVASI (The Greens/EFA, FR), MEP Ms Renate SOMMER (EPP, DE) and MEP Ms
Rebecca TAYLOR (ALDE, UK).
Studio EN
Workshop
"Alzheimer’s Disease and Other Dementias"
Tipo di pubblicazione Studio
Data 28-10-2010
Autore esterno Ms. Vanessa Leigh, Ms. Gretta Goldenman
Milieu Ltd
Brussels, Belgium
Settore di intervento Sanità pubblica
Parole chiave diritti del malato | malattia del sistema nervoso | prevenzione delle malattie | ricerca medica | servizio sanitario |
trattamento sanitario
Riassunto This report summarises the presentations and discussions at a Workshop on
"Alzheimer’s Disease and Other Dementias" held at the European Parliament in
Brussels on Thursday 28 October 2010. The aim of the workshop was to discuss this
issue with representatives of EU institutions, patient associations and scientific
experts, in the context of the preparation of an own initiative report drafted by Ms
Marisa MATIAS, MEP, in response to the European Commission’s Communication on a
European initiative on Alzheimer's disease and other dementias.
Studio EN
Proceedings of the Workshop on "Information to Patient on Medicine Prescriptions"
Tipo di pubblicazione Studio
Data 15-03-2010
Autore esterno Jose Luis Valverde (University of Granada, Spain), Andreas Reimann (Mukoviszidose Institute, Bonn, Germany),
Aleksandra Ewa Zigadlo (Innopharm, Wrocław, Poland) and Theo Raynor (University of Leeds, UK)
Settore di intervento Industria | Sanità pubblica
Parole chiave deontologia professionale | diritti del malato | etichettatura | informazione del consumatore | legislazione farmaceutica |
prodotto farmaceutico | professione sanitaria
Riassunto This report summarises the presentations and discussions at a Workshop on 'Information to patient on prescription
medicines', organised by the ENVI Committee in cooperation with the IMCO Committee, and held at the European
Parliament in Brussels on Thursday 4th of March 2010. The aim of the workshop was to provide MEPs with a
comprehensive and balanced overview on the issues and interests at stake regarding the proposals to amend
Directive 2001/83/EC and Regulation (EC) No 726/2004 (COM(2008)0662-0663).
The legislative proposals are aimed at ensuring the proper functioning of the internal market for medicinal products for
human use, as well as the better protection of EU citizens' health. Pursuant to the proposals, these aims would be
achieved via systematic application of quality standards across the EU, provision of information through diverse
channels, provision of non-promotional information by marketing authorization holders and monitoring and
enforcement measures ensuring compliance, while avoiding unnecessary bureaucracy.
Studio EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 6Workshop-Hearing on Quality and Safety of Organ Donation and Transplantation, Brussels, 19 November
2009
Tipo di pubblicazioneStudio
Data
02-12-2009
Autore esterno Judith Middleton, Antonello Romano, Catherine Ganzleben (Milieu Ltd., Brussels, Belgium)
Settore di intervento
Sanità pubblica
Parole chiavecommercio di organi | diagnostica medica | diritti del malato | istituto ospedaliero | norma di sicurezza | trapianto di
organi
Riassunto This report summarises the presentations and discussions at a Workshop-Hearing on the Quality and Safety of Organ
Donation and Transplantation, held at the European Parliament in Brussels on Thursday 19th November 2009. The
aim of the workshop was to exchange views on the Commission’s 2008 proposal for a Directive of the European
Parliament and of the Council on standards of quality and safety of human organs intended for transplantation
(COM(2008) 818 final) and the associated Action Plan on Organ Donation and Transplantation (2009-2015):
Strengthened Cooperation between Member States (COM(2008) 819/3).
Studio EN
Policy Options for the Proposed Directive on Patient's Rights in Cross-border Healthcare
Tipo di pubblicazione Analisi approfondita
Data15-01-2009
Autore esterno Janne Sylvest and Benita Kidmose Rytz (Rambøll Management, Copenhagen, DENMARK)
Settore di interventoPolitica sociale | Sanità pubblica | Spazio di libertà, sicurezza e giustizia
Parole chiave cooperazione transfrontaliera | diritti del malato | principio di reciproco riconoscimento | professione sanitaria |
qualificazione professionale | sanità pubblica | servizio sanitario | sistema sanitario | trattamento sanitario
Riassunto Introduction
The objective of the study is to highlight policy options in relation to the recent proposal put forth by the European
Commission for a directive on the application of patient’s rights in cross-border healthcare. [...]
Analisi approfondita EN
The Impact of the European Court of Justice Case Law on National Systems for Cross-Border Health
Service Provision
Tipo di pubblicazione Studio
Data 15-01-2007
Autore esterno Janne Sylvest (Ramboll Management, Copenhagen, DENMARK), Claus Adamsen (Ramboll Management,
Copenhagen, DENMARK), Andrew Beale (Susie Page (Matrix Research and Consultancy, London, UK) and Susie
Page (Matrix Research and Consultancy, London, UK)
Settore di intervento Diritto UE: sistema e atti giuridici | Sanità pubblica
Parole chiave cooperazione transfrontaliera | diritti del malato | giurisprudenza (UE) | servizio sanitario | sistema sanitario | spese
sanitarie | trattamento sanitario
Riassunto Executive summary
Cross-border health care is an issue of growing importance in the European Union. This briefing note provides
information on the structure of health care systems with respect to cross-border health care in selected Member
States. It examines to what extent rulings from the European Court of Justice (ECJ) have caused Member States to
make legislative or administrative changes, and the challenges that have been experienced in this regard.
Although patient mobility has increased, the current volume of patient mobility seems to be relatively low (around 1% of
overall public expenditure on healthcare). Cross-border challenges predominantly concern planned healthcare as
opposed to other forms of care. For planned care, the key challenge is the nature of the authorisation procedures
which remain in place as a way of protecting national systems. The terms and application of the authorisation scheme
are the central subject matter for the ECJ judgments. [...]
Studio EN
05-10-2022 Fonte : © Unione europea, 2022 - PE 7You can also read
